Hoerter Steven L. — SEC insider filings

SEC reporting owner CIK 1533451. 36 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 36 filings on record, filed 2020-08-24 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Deciphera Pharmaceuticals, Inc.President and CEO, Director13—4 legs · 89,782 sh · $1,327,97422
MBX Biosciences, Inc. (MBX)Chairman, President and CEO, Director111 leg · 20,000 sh · $264,9841 leg · 4,893 sh · $268,23411
CONSTELLATION PHARMACEUTICALS INC (CNST)Director3——6
Oric Pharmaceuticals, Inc. (ORIC)Director6——6
C4 Therapeutics, Inc. (CCCC)Director3——3

Insider filings — Hoerter Steven L.

FiledFormIssuerReported transactionsSource
2026-11-124MBX Biosciences, Inc. (MBX)Sale (S): 4,893 @ $54.82EDGAR
2026-08-044MBX Biosciences, Inc. (MBX)Grant/award (A): 71,000 @ $0 · Grant/award (A): 331,000 (derivative) @ $0EDGAR
2026-06-264C4 Therapeutics, Inc. (CCCC)Grant/award (A): 62,000 (derivative) @ $0EDGAR
2026-06-054MBX Biosciences, Inc. (MBX)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-044MBX Biosciences, Inc. (MBX)Grant/award (A): 11,938 @ $0 · Grant/award (A): 74,249 (derivative) @ $0EDGAR
2026-04-224/AMBX Biosciences, Inc. (MBX)Grant/award (A): 33,751 (derivative) @ $0EDGAR
2026-04-224/AMBX Biosciences, Inc. (MBX)Grant/award (A): 0 (derivative) @ $0EDGAR
2026-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-11-254MBX Biosciences, Inc. (MBX)Grant/award (A): 8,000 (derivative) @ $0EDGAR
2025-11-074MBX Biosciences, Inc. (MBX)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-10-204MBX Biosciences, Inc. (MBX)Purchase (P): 20,000 @ $13.25EDGAR
2025-06-204C4 Therapeutics, Inc. (CCCC)Grant/award (A): 35,500 (derivative) @ $0EDGAR
2025-06-064MBX Biosciences, Inc. (MBX)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-04-094MBX Biosciences, Inc. (MBX)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2025-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-11-214C4 Therapeutics, Inc. (CCCC)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-06-144Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 25,600 (derivative) @ $0EDGAR
2024-06-114Deciphera Pharmaceuticals, Inc.Grant/award (A): 286,075 · Disposition to issuer (D): 286,075 · Code (U): 72,763 · Disposition to issuer (D): 395,735 (derivative) · Disposition to issuer (D): 270,357 (derivative) · Disposition to issuer (D): 415,000 (derivative) · +2 moreEDGAR
2024-02-204Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 298,100 (derivative) @ $0EDGAR
2023-12-144Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 62,500 · Sale (S): 30,664 @ $15.37EDGAR
2023-10-314Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 62,500 · Sale (S): 21,573 @ $12.02EDGAR
2023-06-154Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 20,500 (derivative) @ $0EDGAR
2023-03-234Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 7,500 @ $15.57EDGAR
2023-02-164Deciphera Pharmaceuticals, Inc. (DCPH)Sale (S): 30,045 @ $16 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2022-06-174Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 50,283 (derivative) @ $0EDGAR
2022-03-234Deciphera Pharmaceuticals, Inc. (DCPH)Tax withholding (F): 3,150 @ $9.11EDGAR
2022-01-204Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 415,000 (derivative) @ $0EDGAR
2021-12-174Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 270,357 (derivative) @ $0EDGAR
2021-08-164Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 33,250 (derivative) @ $0EDGAR
2021-07-234/ACONSTELLATION PHARMACEUTICALS INC (CNST)Disposition to issuer (D): 26,342 (derivative)EDGAR
2021-07-194CONSTELLATION PHARMACEUTICALS INC (CNST)Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 13,171 (derivative) · Disposition to issuer (D): 26,342 (derivative) · Disposition to issuer (D): 13,171 (derivative)EDGAR
2021-06-044CONSTELLATION PHARMACEUTICALS INC (CNST)Grant/award (A): 13,171 (derivative) @ $0EDGAR
2021-03-224Deciphera Pharmaceuticals, Inc. (DCPH)Tax withholding (F): 700 @ $42.39 · Tax withholding (F): 2,450 @ $43.19EDGAR
2021-02-184Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 210,000 (derivative) @ $0EDGAR
2021-01-254Deciphera Pharmaceuticals, Inc. (DCPH)Option exercise (M): 1,078 @ $25.40 · Option exercise (M): 1,078 (derivative) @ $0EDGAR
2020-08-244Deciphera Pharmaceuticals, Inc. (DCPH)Option exercise (M): 187 @ $25.40 · Option exercise (M): 187 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1533451 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs